Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group All patients had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback